There are several reasons. Now remember that for a long time, for most of the 20th century, you couldn't make it stable. And so, the product had to be made, hospitals often made it bedside because you couldn't put it in a bottle and ship it across the country. Now you can, so that's a big change. The other reason is the very fact that it's a natural product, and you can’t patent it.

 

It means that you can't brand your particular HOCl because everybody else can make HOCl. And that puts it in a different category from so many other pharmaceutical and medicinal products.

 

The breakthrough we've got with recognition of its extraordinary usefulness and power and the endorsement of an international agency, WHO, I think will move HOCl into the front line. And people will find themselves depending on it. And they'll be making it on site in large volumes in the near future. That's my hope.

 

-- Jeffrey F. Williams, PhD, BVSc, MRCVS, microbiologist and infectious disease expert, has devoted his career to researching, inventing and bringing to market solutions that have improved the lives and health of people all over the world. 

 

-- Professor of Microbiology and Molecular Genetics, Michigan State University (Emeritus)

 

-- Elected Fellow of the American Association for the Advancement of Science (AAAS)

 

-- Holder of 30+ patents covering water treatment, disease control, odor control

 

-- Author of 200+ scientific papers and textbook chapters

 

-- Member of the Board of Counselors, National Institute of Allergy and Infectious Diseases, National Institute of Health (1984-88)

 

-- ​Chairman of a World Health Organization research committee on tropical diseases (based in Geneva) (1985-1989)

 

-- Chief Science Officer, HOCL producer that is world leader in hypochlorous acid technology and manufacturing (2014-2024)